Earnings Feed
Start Free
GYRE THERAPEUTICS, INC.·4

Nov 1, 6:15 AM ET

Chen Ruoyu 4

4 · GYRE THERAPEUTICS, INC. · Filed Nov 1, 2023

Insider Transaction Report

Form 4
Period: 2023-10-31
GYRE THERAPEUTICS, INC.GYRE
Chen Ruoyu
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-10-31+34,380→ 34,380 total
    Exercise: $6.93Exp: 2033-10-31→ Common Stock (34,380 underlying)
Footnotes (1)
  • [F1]These options are vested in full.

Documents

1 file
  • 4
    form4.xmlPrimary